首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Simultaneous detection of human bocavirus and adenovirus by multiplex real-time PCR in a Belgian paediatric population.
【24h】

Simultaneous detection of human bocavirus and adenovirus by multiplex real-time PCR in a Belgian paediatric population.

机译:通过多重实时PCR同时检测比利时小儿人群中的人博卡病毒和腺病毒。

获取原文
获取原文并翻译 | 示例
       

摘要

Since the discovery of human bocavirus (hBoV), the virus has been detected worldwide in respiratory tract samples from young children by various polymerase chain reaction (PCR) assays and real-time PCRs (Q-PCR). Until now, no data have been reported on the presence of hBoV in Belgium and the detection of hBoV in a multiplex Q-PCR setting has not been described. The aim of this study was to develop a fast and reliable multiplex Q-PCR for the simultaneous detection of hBoV DNA and adenovirus (AdV) DNA. During the winter of 2004-2005, 445 nasopharyngeal aspirates (NPAs) were analysed from 404 Belgian children up to 5 years old with acute respiratory tract infections (ARTIs). (Co)infections with hBoV, AdV, respiratory syncytial virus (RSV), human metapneumovirus (hMPV) and influenza A virus were investigated. A viral agent was detected in 61% (n = 272/445) of the NPAs. Multiplex Q-PCR found a prevalence of 11% (n = 51/445) hBoV and 13% (n = 58/445) AdV. Coinfections were more frequently found with AdV (62%; n = 36/58) than with hBoV (49%; n = 25/51). Follow-up samples were available from 22 patients with ARTIs. In three patients, hBoV DNA persisted for one month. Multiplex Q-PCR may help in closing the diagnostic gap by addressing a broader range of potential respiratory pathogens.
机译:自发现人类博卡病毒(hBoV)以来,已通过各种聚合酶链反应(PCR)测定法和实时PCR(Q-PCR)在全球幼儿呼吸道样本中检测到该病毒。迄今为止,比利时尚无关于hBoV存在的报道,并且尚未描述在多重Q-PCR设置中检测hBoV的情况。这项研究的目的是开发一种快速可靠的多重Q-PCR,用于同时检测hBoV DNA和腺病毒(AdV)DNA。在2004-2005年冬季,对404位5岁以下的比利时急性呼吸道感染(ARTIs)儿童进行了445例鼻咽抽吸物(NPA)的分析。研究了hBoV,AdV,呼吸道合胞病毒(RSV),人间质肺病毒(hMPV)和A型流感病毒的(共)感染。在61%(n = 272/445)的NPA中检测到病毒制剂。多重Q-PCR的流行率为11%(n = 51/445)hBoV和13%(n = 58/445)AdV。与hBoV(49%; n = 25/51)相比,AdV(62%; n = 36/58)的合并感染更为常见。可以从22例ARTI患者中获得随访样本。在三名患者中,hBoV DNA持续了一个月。多重Q-PCR可通过解决更广泛的潜在呼吸道病原体来帮助缩小诊断差距。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号